{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0003-0371",
      "generic_name": "BELATACEPT",
      "labeler_name": "E.R. Squibb & Sons, L.L.C.",
      "brand_name": "NULOJIX",
      "active_ingredients": [
        {
          "name": "BELATACEPT",
          "strength": "250 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0003-0371-13",
          "description": "1 VIAL, SINGLE-USE in 1 CARTON (0003-0371-13)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE",
          "marketing_start_date": "20110615",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "E.R. Squibb & Sons, L.L.C."
        ],
        "rxcui": [
          "1112976",
          "1112980"
        ],
        "spl_set_id": [
          "c16ac648-d5d2-9f7d-8637-e2328572754e"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000182829",
          "N0000182830",
          "N0000182150",
          "N0000182151"
        ],
        "pharm_class_pe": [
          "T Lymphocyte Costimulation Activity Blockade [PE]"
        ],
        "pharm_class_epc": [
          "Selective T Cell Costimulation Blocker [EPC]"
        ],
        "pharm_class_moa": [
          "CD80-directed Antibody Interactions [MoA]",
          "CD86-directed Antibody Interactions [MoA]"
        ],
        "unii": [
          "E3B2GI648A"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
      "spl_id": "9057087d-7e59-4e5a-8e4a-96a532efb0ab",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20110615",
      "product_id": "0003-0371_9057087d-7e59-4e5a-8e4a-96a532efb0ab",
      "application_number": "BLA125288",
      "brand_name_base": "NULOJIX",
      "pharm_class": [
        "CD80-directed Antibody Interactions [MoA]",
        "CD86-directed Antibody Interactions [MoA]",
        "Selective T Cell Costimulation Blocker [EPC]",
        "T Lymphocyte Costimulation Activity Blockade [PE]"
      ]
    }
  ]
}